Exosome Technologies Market: Overview

Exosomes are extracellular vehicles produced by most of the cells. These are present in various body fluids and usually contain RNA and specific set of proteins. Exosomes play an important role intercellular communication. These can transfer molecules from one cell to another. Exosomes are being tested for therapeutic applications such as biomarkers, drug delivery systems, and therapies for diseases such as cancer and cardiovascular diseases. An article published by NCBI stated that exosomes have immunotherapeutic applications or can act as a drug delivery system for targeted therapies with drugs and biomolecules. This is due to their ability to selectively express proteins. Additionally, various studies have shown the potential applications of exosomes in drug and nucleic acid delivery, biomarkers, and anticancer vaccines.

Exosome Technologies Market: Key Trends

Increase in awareness about exosome technologies, rise in prevalence of chronic disorders such as cancer and cardiovascular diseases, improved health care infrastructure, rise in R&D spending, technological advancements, surge in investment by major players in the development of treatments, rich product pipeline, and increase in government initiatives are the major drivers of the global exosome technologies market. However, lack of skilled professionals and stringent regulatory procedures are projected to act as major restraints of the global market.

Exosome Technologies Market: Segmentation

The global exosome technologies market can be segmented based on biomolecule type, application, end-user, and region. In terms of biomolecule type, the global market can be classified into non-coding RNAs, mRNA, proteins / peptides, DNA fragments, and lipids. The non-coding RNAs segment dominated the market in 2018, and the trend is projected to continue during the forecast period. Growth of the segment is attributed to wide use of RNAs in the development for therapeutics and diagnostics for various diseases. Based on application, the global exosome technologies market can be divided into drug discovery, drug delivery, oncology, neurodegenerative diseases, cardiovascular diseases, infectious diseases, and others. The drug delivery segment dominated the market in 2018 and is expected to continue its dominance during the forecast period. This is attributed to increase in research initiatives for the development of exosome as drug delivery system. An article published by NCBI indicated that exosomes have shown significant potential in the delivery of drugs or biomolecules in cell therapy treatments. In terms of end-user, the global market can be categorized into health care providers, pharmaceutical & biotechnology companies, and others. The pharmaceutical & biotechnology companies segment dominated the market in 2018 due to high preference for this channel of distribution. The segment is likely to sustain its leadership position from 2019 to 2027.

Exosome Technologies Market: Regional Analysis

In terms of region, the global exosome technologies market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2018 and is projected to constitute significant market share during the forecast period. The market in the region is anticipated to grow at a rapid pace due to increase in geriatric population, rise in prevalence of chronic diseases such as cancer and cardiovascular diseases, technological advancements, and surge in acceptance of these technologies in the region. The market in Asia Pacific is expected to expand at a high CAGR in the next few years, driven by technological advancements, increase in research spending, and improvement in health care infrastructure in developing countries.

Exosome Technologies Market: Competitive Landscape

Major players operating in the global exosome technologies market include Thermo Fisher Scientific, Inc., Danaher, Fujifilm, Lonza, Illumina, Inc., Qiagen, Takara Bio Company, Exocome Diagnostics, and ExoCan Healthcare Technologies Pvt. Ltd.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.